SCHEMBL5323944

SCHEMBL5323944

COc1cc(CC(=O)NCCC(C)c2ccccc2)ccc1OCc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 2/20 0.59
MTNR1B P49286 2/20 0.59
KMT2A Q03164 4/20 0.55
MEN1 O00255 3/20 0.55
ALDH1A1 P00352 3/20 0.55
RAF1 P04049 1/20 0.52
MAP2K1 Q02750 1/20 0.52
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
PKM P14618 1/20 0.52
TRPM8 Q7Z2W7 1/20 0.51
CTSD P07339 1/20 0.50
PDK2 Q15119 1/20 0.50
POLB P06746 2/20 0.49
HTT P42858 2/20 0.49
LMNA P02545 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
CYP1A2 P05177 1/20 0.48
CYP2C19 P33261 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18736058 0.85 MTNR1A (0.72) MTNR1AMTNR1BKMT2AMEN1ALDH1A1
SCHEMBL6376395 0.84 MTNR1A (0.71) MTNR1AMTNR1BKMT2AMEN1ALDH1A1
SCHEMBL14027269 0.83 ALDH1A1 (0.72) MTNR1AMTNR1BKMT2AMEN1ALDH1A1
SCHEMBL14027267 0.83 ALDH1A1 (0.72) MTNR1AMTNR1BKMT2AMEN1ALDH1A1
SCHEMBL9416664 0.82 NPC1 (0.69) MTNR1AMTNR1BKMT2AMEN1ALDH1A1
SCHEMBL5211526 0.82 MTNR1A (0.82) MTNR1AMTNR1BKMT2AMEN1ALDH1A1
SCHEMBL6376361 0.81 ALDH1A1 (0.73) MTNR1AMTNR1BKMT2AMEN1ALDH1A1
SCHEMBL6377560 0.81 ALDH1A1 (0.73) MTNR1AMTNR1BKMT2AMEN1ALDH1A1
SCHEMBL17212227 0.80 MTNR1A (0.66) MTNR1AMTNR1BKMT2AMEN1ALDH1A1
SCHEMBL6095074 0.80 POLB (0.60) KMT2AMEN1ALDH1A1PKMCTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007120083-A1 THE USE OF CARBOXAMIDE DERIVATIVES IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF INFLAMMATORY, ALLERGIC AND DERMATOLOGICAL CONDITIONS ASTRAZENECA AB (SE) 2007-10-25 WO disclosed